霍奇金淋巴瘤的三线挽救化疗
Third-line salvage chemotherapy in Hodgkin's disease.
作者信息
Bonadonna G, Viviani S, Valagussa P, Bonfante V, Santoro A
出版信息
Semin Oncol. 1985 Mar;12(1 Suppl 2):23-5.
PMID:2579440
Abstract
CEP (CCNU, etoposide, and prednimustine) was tested as third-line chemotherapy in 40 patients resistant to both MOPP and ABVD. The observed response rate (complete remission, 35%, and partial remission, 25%) is encouraging. Treatment was generally well tolerated and all acute side effects were reversible.
摘要
CEP（洛莫司汀、依托泊苷和泼尼松氮芥）作为三线化疗方案，在40例对MOPP和ABVD均耐药的患者中进行了测试。观察到的缓解率（完全缓解率为35%，部分缓解率为25%）令人鼓舞。治疗通常耐受性良好，所有急性副作用都是可逆的。
Zotero 插件